WO1999048506A3 - Zusammensetzung zur pharmazeutischen anwendung und/oder zur ernährungsergänzung bei mensch oder tier, die mindestens eine metall-hefe enthält - Google Patents

Zusammensetzung zur pharmazeutischen anwendung und/oder zur ernährungsergänzung bei mensch oder tier, die mindestens eine metall-hefe enthält Download PDF

Info

Publication number
WO1999048506A3
WO1999048506A3 PCT/DE1999/000732 DE9900732W WO9948506A3 WO 1999048506 A3 WO1999048506 A3 WO 1999048506A3 DE 9900732 W DE9900732 W DE 9900732W WO 9948506 A3 WO9948506 A3 WO 9948506A3
Authority
WO
WIPO (PCT)
Prior art keywords
humans
animals
composition containing
nutrition supplement
metal yeast
Prior art date
Application number
PCT/DE1999/000732
Other languages
English (en)
French (fr)
Other versions
WO1999048506A2 (de
Inventor
Leo Mauren
Andrea Drewski
Martin Siegmund
Sylke Wendt
Original Assignee
Roche Consumer Health Worldwid
Leo Mauren
Andrea Drewski
Martin Siegmund
Sylke Wendt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Consumer Health Worldwid, Leo Mauren, Andrea Drewski, Martin Siegmund, Sylke Wendt filed Critical Roche Consumer Health Worldwid
Priority to AU36995/99A priority Critical patent/AU3699599A/en
Priority to EP99919087A priority patent/EP1066046A2/de
Publication of WO1999048506A2 publication Critical patent/WO1999048506A2/de
Publication of WO1999048506A3 publication Critical patent/WO1999048506A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A23L33/165—Complexes or chelates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Es wird eine Zusammensetzung zur pharmazeutischen Anwendung und/oder zur Ernährungsergänzung bei Mensch oder Tier mit mindestens einem, in einer Matrix eingebetteten Wirkstoff, der im Körper über einen längeren Zeitraum freigesetzt wird, beschrieben. Hierbei enthält die Zusammensetzung desweiteren mindestens eine Metall-Hefe.
PCT/DE1999/000732 1998-03-23 1999-03-16 Zusammensetzung zur pharmazeutischen anwendung und/oder zur ernährungsergänzung bei mensch oder tier, die mindestens eine metall-hefe enthält WO1999048506A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU36995/99A AU3699599A (en) 1998-03-23 1999-03-16 Composition for pharmaceutical use and/or for use as a nutrition supplement, forhumans or animals
EP99919087A EP1066046A2 (de) 1998-03-23 1999-03-16 Zusammensetzung zur pharmazeutischen anwendung und/oder zur ernährungsergänzung bei mensch oder tier, die mindestens eine metall-hefe enthält

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19812753A DE19812753C1 (de) 1998-03-23 1998-03-23 Zusammensetzung zur pharmazeutischen Anwendung und/oder zur Ernährungsergänzung bei Mensch oder Tier
DE19812753.7 1998-03-23

Publications (2)

Publication Number Publication Date
WO1999048506A2 WO1999048506A2 (de) 1999-09-30
WO1999048506A3 true WO1999048506A3 (de) 1999-12-09

Family

ID=7862015

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE1999/000732 WO1999048506A2 (de) 1998-03-23 1999-03-16 Zusammensetzung zur pharmazeutischen anwendung und/oder zur ernährungsergänzung bei mensch oder tier, die mindestens eine metall-hefe enthält

Country Status (4)

Country Link
EP (1) EP1066046A2 (de)
AU (1) AU3699599A (de)
DE (1) DE19812753C1 (de)
WO (1) WO1999048506A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004080210A1 (en) * 2003-03-14 2004-09-23 Boehringer Ingelheim Danmark A/S Compositions of dietary metals for support of the physiological intestinal development and prevention of diarrhoea
WO2015099727A1 (en) 2013-12-26 2015-07-02 Hill's Pet Nutrition, Inc. High nutrient yeast

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3743641A1 (de) * 1987-12-22 1989-07-06 Gerhard Dipl Chem Dr Ludwig Verwendung von riboflavin (vitamin b2) bei nahrungsmitteln
WO1994027624A1 (fr) * 1993-05-22 1994-12-08 Junyao Li Formulations de prevention du cancer contenant des vitamines et des mineraux
DE4413839C1 (de) * 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Kombinationspräparat
DE4437403A1 (de) * 1994-10-19 1996-04-25 Mann Gerhard Chem Pharm Fab Antioxidativum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105177A1 (en) * 1992-09-14 1994-03-15 Willem Jacob Serfontein Pharmaceutical preparations for lowering homocysteine levels
DE19530882A1 (de) * 1995-08-11 1997-02-13 Thomas Dr Ing Loeser Arzneimittel zur Vorbeugung, Begleittherapie und Heilung von Geschwulstkrankheiten

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3743641A1 (de) * 1987-12-22 1989-07-06 Gerhard Dipl Chem Dr Ludwig Verwendung von riboflavin (vitamin b2) bei nahrungsmitteln
WO1994027624A1 (fr) * 1993-05-22 1994-12-08 Junyao Li Formulations de prevention du cancer contenant des vitamines et des mineraux
DE4413839C1 (de) * 1994-04-21 1995-10-19 Fritz Koch Pharma Gmbh Dr Med Kombinationspräparat
DE4437403A1 (de) * 1994-10-19 1996-04-25 Mann Gerhard Chem Pharm Fab Antioxidativum

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 9503, Derwent World Patents Index; Class B05, AN 95-022457, XP002115762 *

Also Published As

Publication number Publication date
WO1999048506A2 (de) 1999-09-30
DE19812753C1 (de) 1999-09-09
AU3699599A (en) 1999-10-18
EP1066046A2 (de) 2001-01-10

Similar Documents

Publication Publication Date Title
HK1044545A1 (zh) 貝他分泌酶組合物及其方法
WO1998030203A3 (de) Transdermales therapeutisches system
EP1813286A3 (de) Pharmazeutische Zusammensetzung enthaltend eine Angiotensin-II antagonistisch wirkende Verbindung in Kombination mit einer anderen Verbindung
CA2285005A1 (en) Sequential release throat drops for relief of cough and cold
CA2255891A1 (en) Compositions and methods for treating or preventing diseases of body passageways
HUP0004310A3 (en) Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents
IL154888A0 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
MXPA03008062A (es) Composiciones desodorantes y antitranspirantes anhidras que contienen un agente dermoactivo solido soluble en el agua.
CA2368574A1 (en) Compositions for preventing and treating type i allergy
EP0938899A3 (de) Mittel zur Verbesserung der Blutzirkulation
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
HUP0300357A3 (en) Control of parasites in animals, the novel active ingredients applied and compositions containing the same
ZA948162B (en) Dihaiopropene compound, insecticide/acaricide, containing said dihalopropene compound as active ingredient, and intermediate compound for use in production of said dihalopropene compound.
EP1066824A3 (de) Reizmittel und anreizende Riechstoffzusammensetzung
WO2001085188A3 (en) Use of echinacea as a hematinic agent
EP1240902A4 (de) Carbonyl-stress mildernde substanzen
WO1999048506A3 (de) Zusammensetzung zur pharmazeutischen anwendung und/oder zur ernährungsergänzung bei mensch oder tier, die mindestens eine metall-hefe enthält
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
WO2003011247A3 (de) Trägermatrix mit wirkstoffbeladenen partikeln zur anwendung auf der haut oder schleimhaut
WO1998006409A3 (de) Vitamin a-haltige zusammensetzung und deren verwendung insbesondere gegen hauterkrankungen
CA2267059A1 (en) Sordarin derivatives
CA2279962A1 (en) An anhydrous antiperspirant composition comprising a pentane propellant
WO2000033787A3 (fr) Composition cosmetique deodorante

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN ID JP KR MX PL SG TR US VN ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN ID JP KR MX PL SG TR US VN ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999919087

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: 1999919087

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1999919087

Country of ref document: EP